Elektrofi

company

About

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$224.92K
Industries
Alternative Medicine,Biotechnology,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience. Elektrofi’s formulation system can effectively process a wide range of therapeutic molecules. Their technology has the capacity to process large, increasingly complex and delicate proteins including monoclonal antibodies, bispecifics and fusion proteins.

Founded in 2016, Elektrofi is based in Boston, Massachusetts, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.85M
Elektrofi has raised a total of $1.85M in funding over 2 rounds. Their latest funding was raised on Sep 5, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 5, 2018 Grant $1.63M 1 National Science Foundation Detail
Jun 29, 2017 Grant $224.92K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Elektrofi is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant